Colitis: all 1,059 studies

Page 4 of 11. Open to participants first (124), then studies with results posted, then the rest; newest registration first within each.

• A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.CompletedNCT00787202Phase 2Results posted
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT00783718Phase 3Results posted
• Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative ColitisTerminatedNCT00748410Phase 2Results posted
• Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative ColitisCompletedNCT00718094Phase 2Results posted
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative ColitisCompletedNCT00713310Phase 3Results posted
• European Safety Registry in Ulcerative Colitis (P04808)CompletedNCT00705484Results posted
• (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative ColitisCompletedNCT00679432Phase 3Results posted
• (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative ColitisCompletedNCT00679380Phase 3Results posted
• Phase II Study of HMPL-004 in Patients With Ulcerative ColitisCompletedNCT00659802Phase 2Results posted
• Dose Escalation and Remission (DEAR)CompletedNCT00652145Phase 4Results posted
• Vitamin D Levels in Children With IBDTerminatedNCT00621257Not applicableResults posted
• The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative ColitisCompletedNCT00620126Phase 3Results posted
• Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's DiseaseCompletedNCT00619489Phase 2Results posted
• A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative ColitisCompletedNCT00616434Phase 2Results posted
• Canadian Active & Maintenance Modified Pentasa StudyCompletedNCT00603733Phase 3Results posted
• Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)CompletedNCT00577473Phase 3Results posted
• Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative ColitisCompletedNCT00573794Phase 3Results posted
• Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical TrialTerminatedNCT00553163Not applicableResults posted
• Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)TerminatedNCT00537316Phase 3Results posted
• A Comparison of Once a Day Dose Compared to 2 Doses/DayCompletedNCT00505778Phase 3Results posted
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative ColitisTerminatedNCT00488774Phase 2/3Results posted
• An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT00488631Phase 3Results posted
• An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT00487539Phase 2/3Results posted
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis StudyCompletedNCT00486031Phase 3Results posted
• An Exploratory Study of Rebamipide in Patients With Active Ulcerative ColitisCompletedNCT00463151Phase 2Results posted
• Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)CompletedNCT00446849Phase 4Results posted
• A Study of Abatacept in Patients With Active Ulcerative ColitisCompletedNCT00410410Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT00408629Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative ColitisCompletedNCT00385736Phase 3Results posted
• Safety and Compliance of Taking Mesalamine Once a Day in Pediatric PatientsTerminatedNCT00349388Not applicableResults posted
• A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative ColitisCompletedNCT00336492Phase 3Results posted
• Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in RemissionCompletedNCT00326209Phase 3Results posted
• A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative ColitisTerminatedNCT00317356Phase 2Results posted
• Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile InfectionCompletedNCT00304356Phase 3Results posted
• Budesonide Versus Placebo for the Treatment of Lymphocytic ColitisTerminatedNCT00217022Phase 2/3Results posted
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative ColitisCompletedNCT00151892Phase 3Results posted
• Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative ColitisCompletedNCT00073021Phase 3Results posted
• A Trial of Rosiglitazone for Ulcerative ColitisCompletedNCT00065065Phase 2Results posted
• Interferon-beta1a (AVONEX) Treatment of Ulcerative ColitisCompletedNCT00048347Phase 2Results posted
• The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative ColitisCompletedNCT07398586Phase 4
• Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Health.CompletedNCT07276464
• Kinetics and Metabolism of Nicotinamide Provided as a Dietary SupplementationCompletedNCT07156929Not applicable
• An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese PatientsCompletedNCT06961435
• Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified AnalysisCompletedNCT06922331
• Carotegrast Methyl in Ulcerative ColitisCompletedNCT06897150Phase 4
• The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative ColitisCompletedNCT06873711
• the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative ColitisCompletedNCT06856031
• An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of VedolizumabCompletedNCT06855862
• Nutritional Counseling Impact on Ulcerative Colitis PatientsCompletedNCT06824038Not applicable
• Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UCCompletedNCT06777706Not applicable
• Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel DiseaseActive, not recruitingNCT06757231Not applicable
• Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative ColitisCompletedNCT06652464
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06598943Phase 2
• Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve RemissionCompletedNCT06583863Not applicable
• Etrasimod for Immune Checkpoint Inhibitor Diarrhea and ColitisWithdrawnNCT06521762Phase 2
• The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative ColitisActive, not recruitingNCT06504784Not applicable
• Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative ColitisCompletedNCT06449820
• A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral AminosalicylatesCompletedNCT06398808Phase 2
• Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis PatientsActive, not recruitingNCT06353828Phase 2
• A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT06281704Phase 1
• Comparison Between Infliximab and Adalimumab on Patients With Ulcerative ColitisCompletedNCT06269185
• A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative ColitisWithdrawnNCT06260267Phase 1
• Energy Expenditure in Patients With Ulcerative Colitis Undergoing SurgeryActive, not recruitingNCT06221995
• Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ StudyWithdrawnNCT06188637Phase 4
• A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their InfantsActive, not recruitingNCT06126835
• A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative ColitisCompletedNCT06080048Phase 1
• Intestinal Biomarker Analysis After ECP for ICI ColitisCompletedNCT06074874
• Bleach and Urine Color in UC Patients Using 5ASAActive, not recruitingNCT06013696Not applicable
• ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASACompletedNCT05992142Phase 4
• A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)CompletedNCT05975047Phase 1
• The Application of Transcriptomics in the Treatment of Ulcerative Colitis With UstekinumabCompletedNCT05896943
• First in Human, Single Ascending Dose StudyCompletedNCT05844592Phase 1
• An Early Phase 2 Clinical Study of KSP-0243CompletedNCT05831670Phase 2
• Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative ColitisWithdrawnNCT05809583
• Assessment of the Effectiveness of Progressive Relaxation Techniques in Individuals With Ulcerative ColitisStatus unknownNCT05788549Not applicable
• Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP)CompletedNCT05780723Not applicable
• Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®Active, not recruitingNCT05771155Phase 3
• Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative ColitisCompletedNCT05761327Not applicable
• A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative ColitisStatus unknownNCT05743010Phase 1
• Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative ColitisStatus unknownNCT05735665Not applicable
• Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.CompletedNCT05728008
• Primary Eosinophilic Colitis in Symptomatic Patients.Status unknownNCT05719727
• Role of Roflumilast in Ulcerative ColitisCompletedNCT05684484Phase 4
• Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative ColitisStatus unknownNCT05680883
• Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease StudyStatus unknownNCT05673278
• Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative ColitisCompletedNCT05656391Not applicable
• Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative ColitisStatus unknownNCT05653791
• The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel DiseaseWithdrawnNCT05652491
• Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative ColitisCompletedNCT05649462
• The Effectiveness of Well-being Therapy on Mental Health and Self-efficacy of Patients With Ulcerative ColitisCompletedNCT05645666Not applicable
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT05644665Phase 3
• the Efficacy and Safety of Diosmin in Patients With Ulcerative ColitisStatus unknownNCT05626166Phase 3
• The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative ColitisStatus unknownNCT05606939
• High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)CompletedNCT05587673Phase 1
• Systems Biology of Gastrointestinal and Related DiseasesTerminatedNCT05579444
• Metformin in Patients With Ulcerative Colitis Treated With MesalamineCompletedNCT05553704Phase 2
• Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative ColitisCompletedNCT05538026Not applicable
• Prognosis in UC After First BiologicalCompletedNCT05530122
• Stool and Serum CMV-PCR in Diagnosing CMV ColitisCompletedNCT05522283
• FIT and Fecal Calprotectin in Patients With Chronic Lower GI SymptomsCompletedNCT05514561

← Colitis overview